#Purdue Pharma

New York (CNN Business) — Purdue Pharma, the maker of OxyContin, has agreed to plead guilty to three federal criminal charges for its role in creating the nation's opioid crisis and will pay more than $8 billion and close down the company. The money will go to opioid treatment and...

WASHINGTON (AP) — Drugmaker Purdue Pharma, the company behind the powerful prescription painkiller OxyContin that experts say helped touch off an opioid epidemic, will plead guilty to federal criminal charges as part of a settlement of more than $8 billion, the Justice Department announced Wednesday. The deal does not release...

BURLINGTON, Vt. (WCAX) - Drugmaker Purdue Pharma, the company behind the powerful prescription painkiller OxyContin, pleaded guilty Wednesday to federal criminal charges as part of an $8 billion settlement. Vermont authorities played a major role in the case that resulted in charges that related to a kickback scheme aimed at...

Federal prosecutors have reached a more than $8 billion settlement with Purdue Pharma that will also have the pharmaceutical giant admit to three criminal charges, including two stemming from a “kickback” scheme uncovered by federal authorities in Vermont. Purdue, as part of the resolution, will plead guilty to conspiring with...

The Justice Department announced on Wednesday a global settlement of civil and criminal investigations into Purdue Pharma's aggressive marketing of opioid medications, including OxyContin. Federal officials have long maintained Purdue's actions helped fuel a prescription opioid epidemic that has killed more than 232,000 Americans, according to the Centers for Disease...

WASHINGTON (AP) — Officials tell AP that OxyContin maker Purdue Pharma will plead guilty to federal charges, agree to $8 billion-plus deal. Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Purdue Pharma LP has reached a $8.34 billion settlement with the U.S. Department of Justice (DOJ) to put an end to lengthy criminal and civil federal probes into its marketing and distribution practices regarding opioid painkillers, notably its OxyContin product. However, since the privately owned company has assets far below $8 billion, the settlement may be largely symbolic, although the controlling Sackler family will pay $225 million to resolve civil suits.

The Justice Department announced a historic $8.3 billion settlement Wednesday with OxyContin-maker Purdue Pharma, capping a long-running federal investigation into the company that, for critics, became a leading symbol of corporations profiting from America’s deadly addiction to opioid painkillers. As part of the deal — the largest such settlement ever...

WASHINGTON -- Officials tell AP that OxyContin maker Purdue Pharma will plead guilty to federal charges, agree to $8 billion-plus deal.

“The American Medical Association recommends that any settlement or judgment stemming from opioid-related litigation be used exclusively for data collection, research, education, overdose prevention, stigma elimination, and evidence-based treatment for substance use disorders and pain. “The nation now is facing a more complicated and deadly drug overdose epidemic due to...

Purdue Pharma, the OxyContin prescription opioid painkiller maker controlled by members of the wealthy Sackler family, is nearing an agreement to plead guilty to criminal charges as part of a broader deal to resolve US justice department investigations into its alleged role in fueling the nation’s opioid crisis, six people familiar with the matter said.

"That is not getting Purdue Pharma out of the business of selling opioids," Connecticut Attorney General William Tong said. Attorneys general from 24 states, including Connecticut, New York, New Jersey and California, and the District of Columbia have sent a letter to U.S. Attorney General William Barr asking that a proposed settlement between the U.S. Department of Justice and OxyContin maker Purdue Pharma not be finalized.

The Trump Administration is poised to make a settlement with Purdue Pharma that it can claim as a victory for opioid victims. But the proposed outcome would leave the company’s owners enormously wealthy—and off the hook for good. This past January, the Justice Department announced the results of investigations into...

Connecticut Attorney General William Tong joined two dozen attorneys general from across the country last week in opposition to a proposed U.S. Department of Justice settlement agreement with Stamford-based Purdue Pharma that would preserve its lucrative Oxycontin business as a public trust. The letter to U.S. Attorney General William Barr,...

A group of 25 state attorneys general oppose a settlement of opioid probes being negotiated with Purdue Pharma and members of the wealthy Sackler family who own it, arguing the deal would improperly entangle state and local officials with future sales of the company’s addictive pain drug OxyContin. In a...